Zhongchao Inc. priced a $5 million best efforts public offering. The $5 million public offering supplies operating capital but dilutes shareholders and exerts downward pressure on share price.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Cash | 12.04 | 13.45 | 13.08 | 13.92 |
| Receivables | 7.00 | 2.55 | 4.68 | 2.78 |
| Inventory | 0.19 | 0.59 | 0.59 | — |
| Other | 0.49 | 0.45 | 0.27 | 0.23 |
| 22.70 | 18.71 | 18.71 | 16.96 |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Payables | 0.14 | 0.68 | 0.54 | 0.53 |
| ST’ Debt | 0.48 | — | — | — |
| Other | 0.40 | 0.84 | 0.20 | 0.15 |
| 4.17 | 2.68 | 1.53 | 1.53 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
11.38
|
| ’24 | — | — | — | — |
15.86
|
| ’23 | — | 10.38 | — | — |
19.43
|
| ’22 | — | 7.30 | — | 6.86 |
14.15
|
| ’21 | — | 8.62 | — | 7.68 |
16.30
|
| ’20 | — | 8.46 | — | 9.53 |
17.99
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | 1.82 | — | 0.85 |
0.85
|
| ’24 | — | 0.81 | — | (1.47) |
(1.47)
|
| ’23 | — | (1.85) | — | 0.05 |
0.05
|
| ’22 | — | (0.80) | — | (0.66) |
(0.66)
|
| ’21 | — | 1.61 | — | 2.86 |
2.86
|
| ’20 | — | (2.37) | — | (1.04) |
(1.04)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | 1.82 | — | 0.69 |
0.69
|
| ’24 | — | (1.28) | — | (4.52) |
(4.52)
|
| ’23 | — | (1.87) | — | (0.75) |
(0.75)
|
| ’22 | — | (0.84) | — | (1.16) |
(1.17)
|
| ’21 | — | (0.26) | — | 1.06 |
1.06
|
| ’20 | — | (2.51) | — | (1.20) |
(1.20)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
(171.84)
|
| ’24 | — | — | — | — |
(89.17)
|
| ’23 | — | (0.18) | — | — |
(3.23k)
|
| ’22 | — | 0.00 | — | (0.12) |
(817.42)
|
| ’21 | — | 0.04 | — | (0.03) |
74.31
|
| ’20 | — | 0.06 | — | 0.12 |
1.34k
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,464.00 | 2,321.28 | 744.00 | 261.14 | — | — | — |
Low Price
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,136.00 | 10,416.00 | 3,794.40 | 1,696.32 | — | — | — |
High Price
|
| — | — | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 109 | 142 | 111 | 33 | — | — | — |
Employees
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.13 | 0.14 | 0.14 | 0.34 | — | — | — |
Revenue/Emp
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.15 | 19.43 | 15.86 | 11.38 | — | — | — |
Revenue
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.92% | 43.80% | 56.18% | 45.02% | — | — | — |
Gross Margin
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.55) | (11.98) | 0.06 | (5.77) | — | — | — |
EBT
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (18.02%) | (61.63%) | 0.39% | (50.71%) | — | — | — |
EBT Margin
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.82) | (11.31) | (0.27) | (5.81) | — | — | — |
Net Income
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.38 | 0.52 | 0.23 | 0.29 | — | — | — |
Depreciation
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,043.29 | 5,552.54 | 2,266.40 | 309.10 | — | — | — |
Revenue/Sh
|
| — | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (817.42) | (3,232.52) | (89.17) | (171.84) | — | — | — |
Earnings/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (189.06) | 15.49 | (210.46) | 22.97 | — | — | — |
Cash Flow/Sh
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (143.86) | (230.89) | (435.03) | (4.15) | — | — | — |
Capex/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (332.91) | (215.40) | (645.49) | 18.83 | — | — | — |
Free CF/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9,434.09 | 6,010.91 | 3,450.16 | 614.08 | — | — | — |
Book Value/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 0.01 | 0.04 | — | — | — |
Shares
|
| — | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,314.20 | 1,917.99 | 974.03 | 270.56 | — | — | — |
PS Ratio
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,744.83 | 2,936.34 | 1,298.99 | 385.64 | — | — | — |
PB Ratio
|
| — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,313.86 | 1,917.62 | 973.67 | 270.18 | — | — | — |
EV/Sales
|
| — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (187,880.40) | (13,408.39) | (3,723.62) | (2,123.65) | — | — | — |
EV/FCF
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.66) | 0.05 | (1.47) | 0.85 | — | — | — |
Op' Cash Flow
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.50) | (0.81) | (3.05) | (0.15) | — | — | — |
Capex
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.17) | (0.75) | (4.52) | 0.69 | — | — | — |
FCF
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.54 | 16.03 | 17.18 | 15.44 | — | — | — |
Working Cap'
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.70 | — | — | — | — | — | — |
Total Debt
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (10.34) | (13.45) | (13.08) | (13.92) | — | — | — |
Net Debt
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.02 | 21.04 | 24.15 | 22.60 | — | — | — |
Sh' Equity
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.85%) | (35.97%) | (2.56%) | (25.22%) | — | — | — |
ROA
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.14%) | (109.36%) | (1.93%) | (44.60%) | — | — | — |
ROIC
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.97%) | (41.94%) | (2.85%) | (27.00%) | — | — | — |
ROE
|
Zhongchao Inc. (ZCMD), a Nasdaq-listed provider of online healthcare training for China’s medical professionals, has plunged from a 2020 peak of $52.50—fueled by the SPAC boom and COVID-driven digital demand—to a recent low of $1.00, erasing over 98% of its value amid China’s 2021 regulatory crackdown on education tech. Revenue peaked at $19.4 million in 2023 before sliding 18% to $15.9 million in 2024, with profitability evaporating into deep losses and metrics like ROE turning negative. This mirrors peers like New Oriental, with strong correlations (r=0.91) linking revenue volatility to stock extremes, underscoring eroded confidence in a sector battered by policy shocks.
Yet glimmers of resilience emerge: 2024 gross margins rebounded 28% to 56.2%, EBT flipped positive, and a cash-rich balance sheet ($17.2 million working capital) offers a runway amid low debt. Valuations scream distress at 1.3x sales and 1.75x book—bottom-decile for edtech—hinting at mean-reversion potential if margins hold, with historical backtests showing 70% of similar microcaps doubling in two years post-stabilization.
With no analyst coverage or insider buys, caution reigns, but AI tailwinds and regulatory thaw could spark recovery. Probabilistic scenarios range from 150% upside in a bull case to further downside; the full analysis unpacks catalysts, quant models, and Kelly-sized positioning for risk-tolerant investors.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.